What can we learn from inflammatory bowel disease in developing countries?

Current Gastroenterology Reports

Volumn 15, Issue 3, 2013, Pages

  Wong, Sunny H ^a   Ng, Siew C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diet; Environment; Epidemiology; Inflammatory bowel disease; Microbiota

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; DEVELOPING COUNTRY; DIET; ENTERITIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INCIDENCE; METAGENOME; PHYSIOLOGY; PREVALENCE; RISK FACTOR; SANITATION; URBANIZATION;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DIET; GENE-ENVIRONMENT INTERACTION; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; METAGENOME; PREVALENCE; RISK FACTORS; SANITATION; URBANIZATION;

MLCS; MLOWN;

EID: 84879918464     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-013-0313-9     Document Type: Article

References (132)

1. Sofaer J. Crohn's disease: the genetic contribution. Gut. 1993;34 (7):869-71. (Pubitemid 23203103)
2. Tysk C et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988;29(7):990-6.
3. Anderson CA et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011;43(3):246-52.
4. Barrett JC et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009;41(12):1330-4.
5. Barrett JC et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40 (8):955-62.
6. Franke A et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42(12):1118-25.
7. Gibson G. Hints of hidden heritability in GWAS. Nat Genet. 2010;42(7):558-60.
8. Ng SC et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm Bowel Dis. 2012;18(6):1164-76.
9. Cosnes J et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1785-1794.e4.
10. Lok KH, Hung HG, Ng CH. Epidemiology and clinical characteristics of ulcerative colitis in Chinese population: experience from a single center in Hong Kong. J Gastroenterol Hepatol. 2008;23:406-10.
11. Yang SK et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14(4):542-9.
12. Lee YM, Fock K, See SJ. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol. 2000;15:622-5. (Pubitemid 30435712)
13. Yao T,Matsui T, Hiwatashi N. Crohn's Disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85-93.
14. Sood A, Midha V, Sood N. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut. 2003;52:1587-90. (Pubitemid 37363442)
15. Al-Shamali MA, Kalaoui M, Patty I. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion. 2003;67:218-24. (Pubitemid 37100202)
16. Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 2000;95:693-8. (Pubitemid 30123904)
17. Abdul-Baki H, ElHajj I, El-Zahabi LM. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2007;13:475-80. (Pubitemid 46668254)
18. Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 1999;94:2961-5. (Pubitemid 29482765)
19. Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10:106-11. (Pubitemid 38332169)
20. Torres EA, De Jesus R, Perez CM. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P R Health Sci J. 2003;22:253-8.
21. Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol. 2002;8:158-61.
22. Molodecky NA et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42. quiz e30.
23. Loftus Jr EV, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin N Am. 2002;31(1):1-20. (Pubitemid 34733030)
24. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646-51. (Pubitemid 39276475)
25. Yang SK, Hong WS, Min YI. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol. 2000;15:1037-42.
26. Wang YF, Zhang H, Ouyang Q. Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis. 2007;8:121-7. (Pubitemid 47161783)
27. Vind I et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274-82. (Pubitemid 43833122)
28. Bernstein CN, Wajda A, Svenson LW. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559-68. (Pubitemid 43980630)
29. Jiang L, Xia B, Li J. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006;12:212-7.
30. Moreno JM, Rubio CE, Torres EA. Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980-1987. Bol Asoc Med PR. 1989;81:214-8.
31. Nguyen GC, Torres EA, Regueiro M. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 2006;101:1012-23. (Pubitemid 43725315)
32. Langholz E, Munkholm P, Davidsen M. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11. (Pubitemid 24195339)
33. Stewenius J, Adnerhill I, Ekelund GR. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum. 1996;39:1019-25. (Pubitemid 26304985)
34. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term followup of 1116 patients. Dig Dis Sci. 1993;38:1137-46. (Pubitemid 23175139)
35. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104(8):2100-9.
36. Kochhar R, Mehta SK, Nagi B. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol. 1991;10:88-9.
37. Kitahora T, Utsunomiya T, Yokota A. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Gastroenterol. 1995;30:5-8.
38. Cao Q, Si JM, Gao M. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China. Chin Med J (Engl). 2005;118:747-52. (Pubitemid 40674366)
39. Fujimoto T et al. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol. 2007;19:229-35.
40. Lawrance IC, Murray K, Hall A. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol. 2004;99:2186-94. (Pubitemid 39524710)
41. Ling KL, Ooi CJ, Luman W. Clinical characteristics of ulcerative colitis in Singapore, a multiracial city-state. J Clin Gastroenterol. 2002;35:144-8. (Pubitemid 34815852)
42. Park SH, Kim YM, Yang SK. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13:278-83.
43. Oriuchi T, Hiwatashi N, Kinouchi Y. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol. 2003;38:942-53. (Pubitemid 37455781)
44. Chow DK, Leong RW, Lai LH. Changes in Crohn's disease phenotype over time in the Chinese population: validation of theMontreal classification system. Inflamm Bowel Dis. 2008;14:536-41. (Pubitemid 351571834)
45. Thia KT, Luman W, Jin OC. Crohn's disease runs a more aggressive course in young Asian patients. Inflamm Bowel Dis. 2006;12:57-61. (Pubitemid 43032453)
46. Aghazadeh R, Zali MR, Bahari A. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691-5. (Pubitemid 43961074)
47. Fidder HH, Avidan B, Lahav M. Clinical and demographic characterization of Jewish Crohn's disease patients in Israel. J Clin Gastroenterol. 2003;36:8-12. (Pubitemid 36005339)
48. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol. 2000;12(1):31-8. (Pubitemid 30072102)
49. Lapidus A. Crohn's disease in Stockholm County during 1990- 2001: an epidemiological update. World J Gastroenterol. 2006;12:75-81. (Pubitemid 43126087)
50. Mekhjian HS et al. Clinical features and natural history of Crohn's disease. Gastroenterology. 1979;77(4 Pt 2):898-906. (Pubitemid 9257853)
51. Freeman HJ. Natural history and clinical behavior of Crohn's disease extending beyond two decades. J Clin Gastroenterol. 2003;37:216-9. (Pubitemid 37010915)
52. Louis E, Collard A, Oger AF. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-82. (Pubitemid 33096034)
53. Papi C et al. Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis. 2005;37(4):247-53. (Pubitemid 41070522)
54. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Med (Baltimore). 1976;55:401-12.
55. Monsen U, Sorstad J, Hellers G. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990;85:711-6. (Pubitemid 20185180)
56. Rankin GB, Watts HD, Melnyk CS. National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914-20. (Pubitemid 9242053)
57. Wang Y, Ouyang Q. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol. 2007;22:1450-5. (Pubitemid 47274580)
58. Park JB, Yang SK, Myung SJ. Clinical characteristics at diagnosis and course of Korean patients with Crohn's disease. Korean J Gastroenterol. 2004;43:8-17.
59. Chang DK, Kim YH, Byeon JS. The current status of ulcerative colitis-associated colorectal cancer in Korea: a KASID study. Korean J Gastroenterol. 2005;46:276-82.
60. Thia KT et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103(12):3167-82.
61. Dobbins 3rd WO. Dysplasia and malignancy in inflammatory bowel disease. Annu Rev Med. 1984;35:33-48.
62. Venkataraman S, Mohan V, Ramakrishna BS. Risk of colorectal cancer in ulcerative colitis in India. J Gastroenterol Hepatol. 2005;20:705-9. (Pubitemid 40733363)
63. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526-35. (Pubitemid 32234798)
64. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol. 1999;94:2918-22. (Pubitemid 29482758)
65. Jayanthi V, Probert CS, Pinder D. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med. 1992;82:125-38.
66. Probert CS, Jayanthi V, Pinder D. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33:687-93.
67. Grossman A, Fireman Z, Lilos P. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970-1980. Hepato-Gastroenterology. 1989;36:193-7. (Pubitemid 19218610)
68. Niv Y, Abukasis G. Prevalence of ulcerative colitis in the Israeli kibbutz population. J Clin Gastroenterol. 1991;13:98-101.
69. Yang H, McElree C, Roth MP. Familial empirical risks for inflammatory bowel disease: differences between Jews and non- Jews. Gut. 1993;34:517-24. (Pubitemid 23093496)
70. Halfvarson J, Jess T, Magnuson A. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis. 2006;12:925-33. (Pubitemid 44498280)
71. Orholm M et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35(10):1075-81.
72. Thompson NP et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ. 1996;312(7023):95-6. (Pubitemid 26015449)
73. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563-73.
74. Gent AE et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 1994;343(8900):766-7.
75. Frangos CC. Inflammatory bowel disease: reviewing an old study under a new perspective. Gut. 2007;56(11):1638-9. (Pubitemid 350033207)
76. Jowett SL et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53 (10):1479-84. (Pubitemid 39265269)
77. Yang G et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697-705.
78. Sakamoto N, Kono S, Wakai K. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11:154-63. (Pubitemid 40711220)
79. Shoda R, Matsueda K, Yamato S. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741-5. (Pubitemid 26126594)
80. Amre DK, D'Souza S, Morgan K. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn/'s disease in children. Am J Gastroenterol. 2007;102:2016-25. (Pubitemid 47301536)
81. Nishida T et al. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. Gut. 1987;28(8):1002-7. (Pubitemid 17119267)
82. Sharon P et al. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology. 1978;75(4):638-40. (Pubitemid 9025499)
83. Eckburg PB et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-8. (Pubitemid 40807514)
84. Frank DN et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780-5. (Pubitemid 350003397)
85. Gophna U et al. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006;44(11):4136-41. (Pubitemid 44737260)
86. Manichanh C et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55(2):205-11. (Pubitemid 43117279)
87. Qin J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65.
88. Grzeskowiak L et al. Distinct gut microbiota in southeastern African and northern European infants. J Pediatr Gastroenterol Nutr. 2012;54(6):812-6.
89. Feller M et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7(9):607-13. (Pubitemid 47268226)
90. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis. 2003;3(8):507-14. (Pubitemid 36919097)
91. Liu Y et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 1995;108(5):1396-404.
92. Ekbom A et al. Crohn's disease after in-utero measles virus exposure. Lancet. 1996;348(9026):515-7. (Pubitemid 26279014)
93. Ekbom A et al. Perinatal measles infection and subsequent Crohn's disease. Lancet. 1994;344(8921):508-10. (Pubitemid 24261568)
94. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet. 2012.
95. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165-73. (Pubitemid 351314294)
96. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57(9):1185-91.
97. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2687-92.
98. Hildebrand H et al. Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease. Scand J Gastroenterol. 2008;43(8):961-6.
99. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-60. (Pubitemid 19280051)
100. Masoli M et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59 (5):469-78. (Pubitemid 38580764)
101. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351(9111):1225-32.
102. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355(21):2226-35. (Pubitemid 44791164)
103. Harjutsalo V, Sjoberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet. 2008;371(9626):1777-82. (Pubitemid 351697953)
104. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51(12):3353-61. (Pubitemid 35403436)
105. Rautiainen H et al. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol. 2007;42(11):1347-53. (Pubitemid 47537072)
106. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911-20.
107. Wang L et al. Emergence and control of infectious diseases in China. Lancet. 2008;372(9649):1598-605.
108. Klement E et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008;103(7):1775-82.
109. Pugazhendhi S et al. Environmental factors associated with Crohn's disease in India. Indian J Gastroenterol. 2011;30 (6):264-9.
110. Mahid SS, Minor KS, Soto RE. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-71.
111. Morita N, Toki S, Hirohashi T. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30:1-4.
112. Jiang L, Xia B, Li J. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study. J Clin Gastroenterol. 2007;41:280-4. (Pubitemid 46340750)
113. Firouzi F, Bahari A, Aghazadeh R. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran. Int J Color Dis. 2006;21:155-9. (Pubitemid 43154435)
114. Fich A, Eliakim R, Sperber AD. The association between smoking and inflammatory bowel disease among Israeli jewish patients. Inflamm Bowel Dis. 1997;3:6-9. (Pubitemid 127726433)
115. Reif S, Klein I, Arber N. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology. 1995;108:1683-7.
116. Reif S, Lavy A, Keter D. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol. 2000;95:474-8. (Pubitemid 30106179)
117. Jang JY, Kim HJ, Jung JH. The role of smoking as a risk factor in inflammatory bowel diseases: single center study in Korea. Korean J Gastroenterol. 2006;47:198-204.
118. Quigley EM. Epigenetics: filling in the 'heritability gap' and identifying gene-environment interactions in ulcerative colitis. Genome Med. 2012;4(9):72.
119. Leong RW et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003;17(12):1465-70. (Pubitemid 36831437)
120. Guo QS et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol. 2004;10(7):1069-71.
121. Yamazaki K et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47(9):469-72. (Pubitemid 34988282)
122. Inoue N et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123 (1):86-91. (Pubitemid 34747528)
123. Croucher PJ et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11(1):6-16. (Pubitemid 36175778)
124. Pugazhendhi S et al. Common NOD2 mutations are absent in patients with Crohn's disease in India. Indian J Gastroenterol. 2008;27(5):201-3.
125. Chua KH et al. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease. J Dig Dis. 2009;10 (2):124-30.
126. Barreiro LB et al. Natural selection has driven population differentiation in modern humans. Nat Genet. 2008;40(3):340-5. (Pubitemid 351311765)
127. Sabeti PC et al. Positive natural selection in the human lineage. Science. 2006;312(5780):1614-20. (Pubitemid 43902654)
128. Monsen U, Brostrom O, Nordenvall B. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol. 1987;22:214-8. (Pubitemid 17024407)
129. Park JB, Yang SK, Byeon JS. Familial occurrence of inflammatory bowel disease in Korea. Inflamm Bowel Dis. 2006;12:1146-51. (Pubitemid 44847472)
130. Yang SK, Loftus Jr EV, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7:260-70. (Pubitemid 32776521)
131. Yoshida Y, Murata Y. Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin N Am. 1990;74:67-90.
132. Qin J et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60.